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2,3,7,8-Tetrachlorobenzo-p-dioxin (TCDD),
a halogenated compound that binds and acti-
vates the aryl hydrocarbon receptor, is a by-
product of numerous industrial processes
including waste incineration (Zook and
Rappe 1994). Dioxin, a known human car-
cinogen [International Agency for Research
on Cancer (IARC) 1997], is also thought to
disturb the reproductive and endocrine sys-
tems (Birnbaum and Tuomisto 2000).
Studies in rats and monkeys suggest that
TCDD may affect ovarian function directly or
indirectly via the pituitary (Gao et al. 2000; Li
et al. 1995a; Moran et al. 2001). In utero and
lactational TCDD exposure in rats has been
associated with reduced ovarian weight and
decreased number of corpus lutea and pre-
antral and antral follicles (Heimler et al. 1998).
Postnatal TCDD exposure in rats has been
related to reduced ovarian weight gain, ovula-
tion rate, and number of follicles as well as
inhibition of follicular rupture (Gao et al.
1999; Roby 2000), morphologic changes in
the ovary, and altered cyclicity with disruption
of the estrous cycle (Kociba et al. 1976; Li
et al. 1995a, 1995b; Roby 2000; Son et al.
1999). Although TCDD does not increase
apoptosis of follicles (Heimler et al. 1998), it
slows follicular maturation (Mattison 1980;
Silbergeld and Mattison 1987). Postnatal
TCDD exposure in monkeys has been asso-
ciated with decreases in serum estradiol and
progesterone, leading to anovulation in some
cases (Allen et al. 1979; Barsotti et al. 1979).
In a study of mature female macaques, a single
TCDD dose (below the maximum in the cur-
rent study) led to long-term effects on ovarian
function (Moran et al. 2001).
Menopause, the cessation of menstruation,
is thought to be caused by a loss of primordial
ovarian follicles, resulting in the decline in
estradiol production and the concomitant
increase in circulating concentrations of follicle-
stimulating hormone (FSH) (Lopez et al.
2000). The age of onset of menopause is
believed to reflect the rate of atrophy of the
ovarian follicles. Alterations in age at meno-
pause can have important health implications
because women with early menopause are at
higher risk for osteoporosis, cardiovascular dis-
ease, and reproductive cancers (Bradsher and
McKinlay 2000; Karagas et al. 2000).
There is limited epidemiologic evidence
that endocrine-disrupting chemicals affect
the natural timing of menopause. Data from
a case–control study of breast cancer in North
Carolina (USA) show that women with
serum dichlorodiphenyldichloroethene
(DDE) levels in the upper 10th percentile
had an earlier onset of natural menopause
than did women with levels below the
median [hazard ratio (HR) = 1.4], but poly-
chlorinated biphenyl (PCB) levels were not
related to age at menopause (Cooper et al.
2002). Women from the Yu-cheng, China,
cohort who ingested cooking oil contaminated
with PCBs and polychlorinated dibenzofurans
did not differ from unexposed women in their
mean age at menopause or in the percentage
of women who had experienced menopause
(Yu et al. 2000). Among Michigan (USA)
women who had been exposed to polybromi-
nated biphenyls (PBBs) and PCBs in 1973, no
association was found between serum concen-
trations of PBBs or PCBs and time to meno-
pause (Blanck et al. 2004). Amenorrhea was
noted in a case report of a 30-year-old Austrian
woman with extremely high levels of serum
TCDD (144,000 ppt) (Geusau et al. 2001).
Additional evidence for the potential effects of
TCDD on the menstrual cycle is our earlier
report of longer menstrual cycles in exposed
women who were premenarcheal at the time of
exposure (Eskenazi et al. 2002).
In this study, we examine the relationship
of TCDD and age of onset of natural meno-
pause in a population of women residing near
Seveso, Italy, in 1976, at the time of a chemical
plant explosion. These women were exposed to
the highest levels of TCDD known in residen-
tial populations (Mocarelli et al. 1988).
Materials and Methods
Study population. The Seveso Women’s
Health Study (SWHS) is the first comprehen-
sive epidemiologic study of the reproductive
health of a female population exposed to
TCDD. Women eligible for SWHS were
1 month to 40 years of age in 1976, had
resided in one of the most highly contaminated
areas (zone A or B), and had adequate stored
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2,3,7,8-Tetrachlorobenzo-p-dioxin (TCDD), a halogenated compound that binds the aryl
hydrocarbon receptor, is a by-product of numerous industrial processes including waste incinera-
tion. Studies in rats and monkeys suggest that TCDD may affect ovarian function. We examined
the relationship of TCDD and age at menopause in a population of women residing near Seveso,
Italy, in 1976, at the time of a chemical plant explosion. We included 616 of the women who par-
ticipated 20 years later in the Seveso Women’s Health Study. All women were premenopausal at
the time of the explosion, had TCDD levels measured in serum collected soon after the explosion,
and were ≥ 35 years of age at interview. Using proportional hazards modeling, we found a 6%
nonsignificant increase in risk of early menopause with a 10-fold increase in serum TCDD. When
TCDD levels were categorized, compared with women in the lowest quintile (< 20.4 ppt), women
in quintile 2 (20.4–34.2 ppt) had a hazard ratio (HR) of 1.1 (p = 0.77), quintile 3 (34.3–54.1 ppt)
had an HR of 1.4 (p = 0.14), quintile 4 (54.2–118 ppt) had an HR of 1.6 (p = 0.10), and quintile
5 (> 118 ppt) had an HR of 1.1 (p = 0.82) for risk of earlier menopause. The trend toward earlier
menopause across the first four quintiles is statistically significant (p = 0.04). These results suggest
a nonmonotonic dose-related association with increasing risk of earlier menopause up to about
100 ppt TCDD, but not above. Key words: 2,3,7,8-tetrachlorodibenzo-p-dioxin, Cox proportional
hazards, dioxin, endocrine disruptors, menopause, Seveso, TCDD. Environ Health Perspect
113:858–862 (2005). doi:10.1289/ehp.7820 available via http://dx.doi.org/ [Online 24 March 2005]
sera collected soon after the explosion (Eskenazi
et al. 2000). Recruitment took place from
March 1996 through July 1998. Of 1,271 eligi-
ble women, 17 could not be contacted, and 33
had died or were too ill to participate. Of the
1,221 women contacted, 981 (80%) agreed to
participate. For this analysis, we included the
616 women who had not reached natural or
surgical menopause before 10 July 1976, the
date of the explosion, and who were at least
35 years of age at the time of interview.
Procedure. Details of the study are pre-
sented elsewhere (Eskenazi et al. 2000). Briefly,
after informed consent was obtained, women
were interviewed by a trained nurse-interviewer
who was blind to TCDD level and residence of
the woman. Information was collected during
the interview about demographic characteris-
tics, personal habits, and occupational, men-
strual, reproductive, and medical histories.
Subsequently, women were asked to undergo a
gynecologic examination with a transvaginal
ultrasound and to complete a menstrual cycle
diary for 3 months. Medical records were
abstracted for all gynecologic treatments or
conditions.
Serum TCDD laboratory analyses. Details
of serum sample selection are presented else-
where (Eskenazi et al. 2000). The TCDD con-
centration in these samples was measured by
high-resolution mass spectrometry methods
(Patterson et al. 1987). Values are reported on
a lipid-weight basis in parts per trillion by
dividing TCDD on a whole-weight basis by
total serum lipid content, estimated from
measurements of triglycerides and cholesterol
(Akins et al. 1989).
We measured TCDD in sera collected
between 1976 and 1977 for 564 women,
between 1978 and 1982 for 28 women, and
between 1996 and 1997 for 24 women whose
earlier samples had insufficient volume. For
nondetectable values (n = 71), a serum TCDD
level equal to one-half the detection limit was
assigned (Hornung and Reed 1990). For
women with detectable post-1977 TCDD
measurements (≥ 10 ppt), the TCDD expo-
sure level was back-extrapolated to 1976 using
the first-order kinetic model (Pirkle et al.
1989) for women who were > 16 years of age
in 1976 (n = 40) or the Filser model (Kreuzer
et al. 1997) otherwise (n = 1). For the 7
women with post-1977 measures whose
TCDD levels were < 10 ppt, measured values
were used. The study median serum sample
weight was 0.65 g, and the median limit of
detection was 18.8 ppt, lipid-adjusted.
Definitions of menopause. Each woman
was categorized by menopausal status using
the following definitions: premenopause, if
the woman was still menstruating or if she
had amenorrhea due to pregnancy or lacta-
tion at the time of interview with evidence of
subsequent menstruation from the menstrual
diary or exam; natural menopause, if the
woman had ≥ 12 months of amenorrhea not
due to other obvious causes such as pregnancy,
lactation, and medical conditions [World
Health Organization (WHO) Scientific Group
1996); surgical menopause, if the woman had
a medical-record–confirmed hysterectomy
and/or a unilateral or bilateral oophorectomy;
impending menopause, if the woman men-
struated within 12 months, but not in the
2 months before interview or exam, whichever
was most recent, and if her amenorrhea could
not be explained by pregnancy, lactation, or
other medical conditions; perimenopause, if
the woman did not menstruate within the last
2 months before interview or exam but either
gave evidence of subsequent menstruation in
her menstrual diary or on ultrasound exam her
endometrial lining was classified as secretory,
indicating ovulation and impending menses, or
if the woman reported cycles becoming less
predictable (either irregular or longer) in the
previous 2–5 years (a woman was not classified
as perimenopausal if she reported a return to
a regular cycle, if there was evidence only for
a single irregular cycle, or if the irregularity
was attributable to another cause); and other
menopausal status, if the woman’s menopausal
status could not be determined because of cur-
rent oral contraceptive (OC) or other hormone
use (including hormone replacement therapy)
or previous chemotherapy for cancer.
Statistical analyses. We considered serum
TCDD levels both a continuous (log10 TCDD)
and a categorical variable based on quintiles of
serum levels near the time of the explosion (1,
< 20.4 ppt; 2, 20.4–34.2 ppt; 3, 34.3–54.1 ppt;
4, 54.2–118.0 ppt; 5, > 118.0 ppt). To evaluate
the relationship between serum TCDD and age
at natural menopause, we performed Cox pro-
portional hazards analyses with the robust
method of calculating the variance-covariance
matrix (Lin and Wei 1989). The Cox model
assesses effects on age-specific probabilities of
reaching natural menopause by the relative haz-
ard, or HR, the ratio of probabilities computed
for each categorized level of exposure versus the
reference group (< 20.4 ppt) or for the effect of
a 10-fold increase in TCDD (log10 TCDD).
Scaled Schoenfeld residuals were generated for
the final multivariate model and used to test the
proportional hazard assumption (i.e., that the
HR is proportional over time) (Grambsch and
Therneau 1994). Analyses were performed
using STATA (release 8.0; Stata Corp., College
Station, TX, USA). All p-values are two-tailed.
Covariates were considered for the multi-
variate Cox proportional hazards analysis if they
had been reported in previous literature to be
related to age at menopause. Covariates were
kept in the multivariate model if they were sta-
tistically significant (p < 0.10) or if they changed
the regression coefficient for TCDD exposure
by > 10%. We considered the following as
potential covariates: current body mass index
(BMI), premenopausal smoking history, edu-
cation, marital status, current physical activity,
age at menarche, parity, OC use, and history of
heart disease. We also created a variable for
premenopausal history of medical conditions
that could potentially be related to age at
menopause, including type 1 diabetes (n = 1),
rheumatoid arthritis (n = 4), radiation for can-
cer (n = 4), epilepsy (n = 2), hyperthyroid
(n = 10), and untreated hypothyroid (n = 2)
(Dorman et al. 2001; Klein et al. 2001;
Steinkampf 1990). In addition to controlling
for these conditions with an indicator variable,
we repeated our models excluding women with
these conditions (n = 23). The results were
similar; therefore, we present only the results
including the women with other medical con-
ditions. One covariate (education) was found
to violate the proportional hazards assumption
(p = 0.06); therefore, estimates stratified by
education were obtained.
For women who met the definition of
natural menopause, age (in years) at last men-
strual period was assigned as their age at
menopause. Surgically menopausal women
were censored at the age at which they had
surgery. Premenopausal and perimenopausal
women were censored at their age at interview.
Women using OCs or other hormones and
those with a history of chemotherapy were
censored at the age at which they began use or
treatment. Each woman was entered into the
analysis at 35 years of age, before which natural
menopause was unlikely to occur. Twenty-seven
women (4%) were censored before 35 years of
age because of surgical menopause (n = 7), OC
use (n = 19), or other hormone use (n = 1).
We reran the final models including as
menopausal the 13 women in the impending
menopause group who may have been meno-
pausal but had not yet reached the definition
of natural menopause (12 months of amenor-
rhea). To assess the possibility that TCDD
exposure is associated with conditions that
would lead to surgical menopause or that it is
associated with a longer menopausal transi-
tion, we also reran the final models with a
redefined outcome including surgical meno-
pause, perimenopause, impending meno-
pause, and natural menopause.
The final models were also rerun consid-
ering alternative TCDD exposure scenarios
including cumulative exposure dose (area
under the curve measured in parts per trillion-
years) and estimated exposure dose at time of
failure or censorship (parts per trillion). These
doses were estimated for each year of exposure
(time dependent) following the first-order
kinetic model assuming a half-life of 9 years
for TCDD (Pirkle et al. 1989). Ages at risk
before the explosion were assigned to the
“unexposed” category. We also reran the final
models excluding the 24 women for whom it
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was necessary to estimate TCDD exposure by
back-extrapolation from TCDD levels meas-
ured in serum collected in 1996.
Results
Characteristics of the 616 women in the analy-
sis are presented in Table 1 for all women and
by menopausal category. The mean (± SD) age
at interview of the 616 women was 47.8 ±
8.1 years and ranged from 35 to 63 years. A
total of 260 women (42.2%) were in pre-
menopause, 169 women (27.4%) were in
natural menopause, 83 women (13.5%) were
in surgical menopause, 13 women (2.1%) were
in impending menopause, 33 (5.4%) were in
perimenopause, and 58 (9.4%) were assigned
other status [current OC use (n = 39), other
hormone use (n = 17), chemotherapy (n = 2)].
The mean (± SD) age at menopause for those
in natural menopause (n = 169) was 49.2 ± 3.7
years (median, 49; range, 39–57), which was
older than those in surgical menopause (42.7 ±
6.2 years; median, 43; range, 22–52).
All women were Caucasian, about half had
less than the required amount of education,
about 40% were overweight or obese (≥ 25
kg/m2), two-thirds had never smoked, about
half had ever used OCs, and nearly all had
been married and were parous (Table 1).
Compared with premenopausal women, nat-
ural menopausal women were less educated
and more likely to be overweight or obese, to
be nonsmokers, to have used OCs for a
shorter period of time, and to have had more
pregnancies.
For each menopausal category, the median
lipid-adjusted serum TCDD level and inter-
quartile range (IQR) are presented in Table 2.
Overall, the median lipid-adjusted serum
TCDD level for the 616 women was 43.7 ppt
(IQR, 24–95 ppt; range, 2.5–6,320 ppt). For
premenopausal women, the median serum
TCDD level was 43.6 ppt (IQR, 21–91 ppt),
and for naturally menopausal women the
median was 45.8 ppt (IQR, 28–100 ppt).
Serum TCDD levels did not vary significantly
across the menopausal categories (analysis of
variance for log10 TCDD, p = 0.87).
In Cox proportional hazards modeling, the
unadjusted HR associated with a 10-fold
increase in TCDD (log10 TCDD) was 1.02
[95% confidence interval (CI), 0.8–1.3; test
for trend, p = 0.89] (Table 3). That is, there
was a 2% nonsignificant increase in risk of
onset of menopause with a 10-fold increase in
TCDD (e.g., from 10 to 100 ppt). After con-
trolling for education, parity, duration of OC
use, and “other medical conditions,” the associ-
ation with log10 TCDD remained nonsignifi-
cant (HR = 1.06; 95% CI, 0.8–1.4). However,
when a square term in log10 TCDD was added
to the continuous variable model, it was statis-
tically significant, suggesting a curvature in the
dose–response curve (results not shown).
When serum TCDD levels were catego-
rized into quintiles, risk of earlier menopause
trended upward in the first four quintiles but
not in the highest quintile in the unadjusted
(Table 3) and adjusted models (Figure 1).
After adjusting for covariates, relative to
women with TCDD levels in the lowest
quintile (< 20.4 ppt), women with TCDD
levels in quintile 2 (20.4–34.2 ppt) had a
10% increase in hazard of natural menopause
(adjusted HR = 1.1; 95% CI, 0.7–1.8; p =
0.77), women with TCDD levels in quintile
3 (34.3–54.1 ppt) had a 40% increase in haz-
ard of natural menopause (adjusted HR = 1.4;
95% CI, 0.9–2.3; p = 0.14), and women with
TCDD levels in quintile 4 (54.2–118 ppt)
had a 60% increase in hazard of natural
menopause (adjusted HR = 1.6; 95% CI,
0.9–2.6; p = 0.10). Women in the highest
quintile (5, > 118 ppt), however, had only
a 10% increase in hazard of earlier natural
menopause (adjusted HR = 1.1; 95% CI,
0.6–1.9; p = 0.82). Although no increasing
trend of earlier natural menopause was
observed across the five quintiles (p = 0.44), a
significant trend to earlier natural menopause
across the first four quintiles was found (p =
0.04). Furthermore, when we excluded the
24 women who had back-extrapolated TCDD
levels from 1996, the association is strength-
ened. Compared with women in the lowest
quintile (< 20.4 ppt), women in quintile 2
(20.4–34.2 ppt) had an HR of 1.2 (p = 0.5);
quintile 3 (34.3–54.1 ppt) had an HR of
1.6 (p = 0.08); quintile 4 (54.2–118 ppt)
had an HR of 1.7 (p = 0.05); and quintile 5
(> 118 ppt) had an HR of 1.2 (p = 0.5) for
risk of earlier menopause. The trend toward
earlier menopause across the first four quin-
tiles is statistically significant (p = 0.02).
The results did not change when women
in the impending menopause category were
classified as menopausal in the analysis (data
not shown). Similar results were found when
women in surgical menopause and peri-
menopause were also combined with natural
and impending menopause as one outcome
(data not shown).
When TCDD exposure was extrapolated
to the time of failure or censorship, the results
Eskenazi et al.
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Table 1. Distribution of select characteristics [n (%)] by menopausal status, SWHS, Italy, 1996–1998 (n = 616).
All Natural Surgical Impending
Characteristic womena Premenopausalb menopauseb menopauseb menopauseb Perimenopauseb Otherb
Menopausal status 616 (100) 260 (42.2) 169 (27.4) 83 (13.5) 13 (2.1) 33 (5.4) 58 (9.4)
Age at interview 47.8 ± 8.1 41.9 ± 4.7 56.6 ± 3.7 52.1 ± 6.4 51.5 ± 2.8 47.1 ± 3.2 41.8 ± 6.6
[years (mean ± SD)]
Education
Less than required 341 (55) 85 (25) 139 (41) 59 (17) 11 (3) 26 (8) 21 (6)
Required/university 275 (45) 175 (64) 30 (11) 24 (9) 2 (1) 7 (3) 37 (13)
Current BMI (kg/m2)
< 18.5 13 (2) 8 (62) 3 (23) 0 (0) 0 (0) 1 (8) 1 (8)
18.5–24.9 353 (57) 170 (48) 80 (23) 37 (10) 6 (2) 18 (5) 42 (12)
25.0–29.9 180 (29) 63 (35) 60 (33) 31 (17) 6 (3) 9 (5) 11 (6)
≥ 30 70 (11) 19 (27) 26 (37) 15 (21) 1 (1) 5 (7) 4 (6)
Cigarette smoking
Never 419 (68) 155 (37) 130 (31) 66 (16) 10 (2) 25 (6) 33 (8)
Former 88 (14) 47 (53) 16 (18) 9 (10) 0 (0) 3 (3) 13 (15)
Current 109 (18) 58 (53) 23 (21) 8 (7) 3 (3) 5 (5) 12 (11)
Total OC use (years)
0 332 (54) 111 (33) 132 (40) 53 (16) 6 (2) 18 (5) 12 (4)
< 1–5 184 (30) 106 (58) 30 (16) 21 (11) 2 (1) 11 (6) 14 (8)
≥ 5 100 (16) 43 (43) 7 (7) 9 (9) 5 (5) 4 (4) 32 (32)
Ever married
No 16 (3) 11 (69) 2 (13) 1 (6) 0 (0) 1 (6) 1 (6)
Yes 600 (97) 249 (42) 167 (28) 82 (14) 13 (2) 32 (5) 57 (10)
Parous
No 49 (8) 32 (65) 8 (16) 5 (10) 0 (0) 1 (2) 3 (6)
Yes 567 (92) 228 (40) 161 (28) 78 (14) 13 (2) 32 (6) 55 (10)
aNo. (%) of column. bNo. (%) of row.
were no different. Cumulative TCDD expo-
sure (parts per trillion-years), however, was not
related to age at onset of menopause (adjusted
HR = 1.02; 95% CI, 0.8–1.3).
In the final models described above, nulli-
parity was associated with earlier natural
menopause (adjusted HR = 1.9; 95% CI,
1.1–3.4), and history of OCs for at least
5 years was associated with later natural
menopause (adjusted HR = 0.5; 95% CI,
0.3–1.1). We observed a nonsignificant earlier
natural menopause for women who were cur-
rent smokers (adjusted HR = 1.2; 95% CI,
0.8–1.7). BMI, however, was not associated
with age at natural menopause.
Discussion
The results of this study of women residing in
Seveso, Italy, in 1976, at the time of a chemical
plant explosion that resulted in very high levels
of TCDD exposure, suggest a nonmonotonic
dose-related association of TCDD levels in sera
collected near the time of exposure with earlier
onset of natural menopause; the trend for
increasing risk is observed with TCDD levels
up to about 100 ppt, but not above. Our find-
ing is supported by the earlier mean age of
menopause observed in our study (49.2 ±
3.7 years) relative to that (mean = 50.9 years)
reported in an Italian clinic-based study of
> 4,300 menopausal women during the same
time period (1995–1997) (Meschia et al. 2000).
It is also earlier than the mean age of 49.9 years
reported contemporaneously for menopausal
women from another unexposed province in the
Lombardia region (Celentano et al. 2003).
To our knowledge, no previous epidemio-
logic studies have examined the relation of
TCDD exposure and age at menopause.
However, amenorrhea was observed in a case
report of an Austrian woman with extremely
high levels of serum TCDD (144,000 ppt)
(Geusau et al. 2001). Our findings are also
consistent with findings from a case–control
study of breast cancer in women residing in
North Carolina (Cooper et al. 2002). In that
study, investigators did not find a relationship
between age at menopause with serum levels
of total PCBs (including dioxin-like and non-
dioxin-like PCBs) but did find an elevated risk
(HR = 1.4) for earlier menopause in women
with serum levels in the top decile of DDE
compared with women with levels below the
median. However, the mechanism of action for
TCDD is not the same as for DDE (Mizuyachi
et al. 2002), and the effects of TCDD may dif-
fer depending on the estrogen-target material
(Chaffin et al. 1996).
The potential impact of TCDD exposure
on age at menopause is biologically plausible,
as animal studies indicate (Kociba et al. 1976;
Li et al. 1995a, 1995b; Roby 2000; Son et al.
1999). In a rat model, a serum estradiol con-
centration 8–10 times higher than normal was
needed to overcome TCDD-blocked ovula-
tion, including restoration of the luteinizing
hormone and FSH surges. This suggests that
the hypothalamic–pituitary axis may be less
sensitive to estrogen in TCDD-treated animals
(Gao et al. 2001).
If TCDD exposure induces earlier meno-
pause, it is unlikely to occur via oocyte apop-
tosis. Recent data in mice suggest that TCDD
does not induce Bax gene expression in oocytes,
which is necessary for the oocyte loss related to
premature ovarian failure (Matikainen et al.
2001). Although this relation remains to be
examined in human cells, the findings on Bax
activation would suggest that TCDD exposure
may not cause premature ovarian failure
(J. Tilly, personal communication).
We observed an inverted U-shaped rela-
tionship between TCDD serum levels and ear-
lier menopause. An inverted U-shaped dose
response has been hypothesized by Kohn and
Melnick (2002) as a plausible outcome with
endocrine-disrupting chemicals. Myers et al.
(2003) hypothesized that at lower “physiologic”
doses a chemical may mimic a hormone, but at
higher doses the toxic effect of the chemical
may overwhelm the stimulatory or inhibitory
effects. Empirical data from animals exposed to
a variety of estrogenic xenobiotics (Rubin et al.
2001; vom Saal et al. 1995) support this theory,
although only one prior study of TCDD
(Markowski et al. 2001) has demonstrated non-
monotonic effects (i.e., of in utero exposure on
adult weight of offspring). The present results
as well as those in animals suggest a reevalua-
tion of the presumed monotonic dose–response
relationships with exposure to endocrine-
disrupting chemicals that are typically tested in
statistical modeling of epidemiologic data.
This study has some limitations. One limi-
tation is the retrospective recall of age of nat-
ural menopause. However, previous studies
have reported moderately high reliability and
accuracy based on interview (Colditz et al.
1987). Further, in the women with surgical
menopause, the reported age at menopause
was similar to the age recorded in the medical
record. In addition, we augmented our classifi-
cation using ultrasound, menstrual diary and
medical record information. We also counted
women who had evidence of impending
menopause as menopausal, and saw a similar
pattern of results.
Although smoking has been associated
with earlier menopause in a number of studies
(Brambilla and McKinlay 1989; Brett and
Cooper 2003; Bromberger et al. 1997; Cooper
et al. 2002; Gold et al. 2001; Meschia et al.
2000; Palmer et al. 2003; Sowers and La Pietra
1995; van Noord et al. 1997; Willett et al.
1983), we did not observe a significant rela-
tionship in the present study of a TCDD-
exposed population. This lack of association
may be due to the paucity of heavy smokers,
or possibly related to an interaction between
different ligand-activated receptor pathways
(Klinge et al. 2000). Another reason for the
lack of association may be that we defined
smoking status as that at interview. Smoking
status at the time of the outcome (if it occurred
before the interview) may have been different.
Another limitation of the study is that the
lowest TCDD exposure group (≤ 20.4 ppt)
experienced relatively high serum levels com-
pared with the contemporary levels we have
reported for this area (~ 2 ppt) (Warner et al.
2004). Also, although the explosion resulted
in exposure specifically to TCDD, pooled
serum samples collected in 1976 from females
who resided in the unexposed area showed
substantial background exposure to other
polychlorinated dibenzo-p-dioxins and PCBs
during this time period [90 ppt dioxin toxic
equivalents (TEQ), on average, for this age
group) (Eskenazi et al. 2004)]. Therefore,
individuals with TCDD levels < 20 ppt might
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Table 3. Serum TCDD levels, percentage with natural
menopause, and unadjusted HRs (95% CIs) for onset
of menopause, SWHS, Italy, 1996–1998 (n = 616).
TCDD (ppt) nmp/ntot (%) HR (95% CI)
Continuous
log10 TCDD 169/616 (27) 1.02 (0.8–1.3)
Quintiles
< 20.4 24/123 (20) 1.0 (reference)
20.4–34.2 35/123 (28) 1.1 (0.7–1.8)
34.3–54.1 41/123 (33) 1.4 (0.9–2.3)
54.2–118 37/124 (30) 1.6 (1.0–2.7)
> 118 32/123 (26) 1.0 (0.6–1.8)
nmp, number of women who reached natural menopause;
ntot, total number of women.
Figure 1. Serum TCDD quintiles and age at natural
menopause: HRs and 95% CIs, SWHS, Italy,
1996–1998 (n = 616), adjusted for education, parity,
duration of OC use, and other medical conditions.
Test for trend across quintiles: quintiles 1–5: p = 0.44;
quintiles 1–4: p = 0.04.
3.00
2.50
2.00
1.50
1.00
0.50
0.00
< 20.4 > 11820.4–34.2 34.3–54.1 54.2–118
Serum TCDD level (ppt, lipid-adjusted)
H
R
1.0 1.1
1.4 1.6
1.1
p = 0.77 p = 0.14 p = 0.10 p = 0.82
Table 2. Distribution of serum TCDD levels near the
time of explosion by menopausal category at inter-
view, SWHS, Italy, 1996–1998 (n = 616).
Serum TCDD
Category No. (%) [median ppt (IQR)]
Premenopause 260 (42.2) 43.6 (21–91)
Natural menopause 169 (27.4) 45.8 (28–100)
Surgical menopause 83 (13.5) 43.4 (28–98)
Impending menopause 13 (2.1) 43.8 (24–105)
Perimenopause 33 (5.4) 36.5 (22–85)
Other 58 (9.4) 39.6 (17–85)
Total 616 (100.0) 43.7 (24–95)
Eskenazi et al.
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still have had substantial dioxin TEQ expo-
sure. Because we could consider only TCDD
in this study, our results may underestimate an
effect due to dioxin TEQ exposure.
An advantage of this study is that we were
able to measure TCDD levels in individual
serum samples collected near the time of expo-
sure, and there was a wide range of exposure.
For the few women whose samples were of
inadequate volume, we used serum collected
between 1996 and 1997. If we exclude these
women, the relation is strengthened. We have
examined multiple exposure scenarios includ-
ing exposure soon after the explosion as well as
exposure extrapolated to each age at risk.
In summary, we observed a nonmonotonic
dose–response relationship between serum
TCDD levels and age of onset of natural
menopause. The women in this study experi-
enced substantial TCDD exposure during the
postpubertal–adult developmental period.
Animal evidence suggests that in utero and lac-
tational TCDD exposure may have significant
effects on ovarian follicles (Heimler et al.
1998); therefore, continued follow-up of
the younger women in the SWHS cohort as
well as the female offspring of the SWHS
cohort is essential.
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